Clinical Trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2019-08-22; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2022-04-11
Trial Details
NCT Number NCT04068155
Lead Sponsor Alpha Tau Medical LTD.
Conditions Skin Cancer, Cutaneous Tumor, Cutaneous Metastasis
Enrollment 80 participants
Start Date 2022-04-01
Primary Completion 2027-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16